Cholinergic synaptic plasticity shapes resilience and vulnerability to tau

Synaptic dysfunction is a hallmark of Alzheimer’s disease (AD). Yet due to their plasticity, synapses may also adapt to early AD pathology. Using within-subject positron emission tomography scans targeting the vesicular acetylcholine transporter (VAChT) protein, tau, and amyloid in healthy older adu...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Onuska, Kate M., Devito, Lauren A., Shanks, Hayley R.C., Qi, Qi, Crooks, Alycia M., Haast, Roy A.M., Andrews, Tallulah S., Williams, Kayla M., Beraldo, Flávio H., Qiu, Ting, Fajardo-Valdez, Alfonso, Wearn, Alfie, Turner, Gary R., Thiessen, Jonathan D., Fox, Matthew S., Hicks, Justin W., Bussey, Timothy J., Saksida, Lisa M., Tremblay-Mercier, Jennifer, Breitner, John C.S., Soucy, Jean-Paul, Poirier, Judes, Villeneuve, Sylvia, Prado, Vania F., Prado, Marco A.M., Spreng, R. Nathan, Schmitz, Taylor W.
Format Paper
LanguageEnglish
Published Cold Spring Harbor Laboratory 28.05.2025
Edition1.1
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Synaptic dysfunction is a hallmark of Alzheimer’s disease (AD). Yet due to their plasticity, synapses may also adapt to early AD pathology. Using within-subject positron emission tomography scans targeting the vesicular acetylcholine transporter (VAChT) protein, tau, and amyloid in healthy older adults at risk for AD, we show that cholinergic neurons increase presynaptic VAChT levels when colocalized to tau, but not amyloid, with higher responses predicting resilience to cognitive decline over ∼10 years. In mice lacking forebrain VAChT, we demonstrate that cholinergic synaptic plasticity plays a causal role in sustaining cognitive flexibility and hippocampal structural integrity. Whole-brain single-nucleus RNA sequencing atlases reveal that cholinergic neurons upregulate a gene-network enriched for synaptic plasticity, with high centrality for the microtubule-associated protein tau (MAPT) gene. Our findings identify cholinergic synaptic plasticity as a critical mediator of resilience and vulnerability to tau in presymptomatic AD.
Bibliography:Competing Interest Statement: J.P. serves as a scientific advisor to the Alzheimer Foundation of France. T.J.B and L.M.S have established a series of targeted cognitive tests for animals, administered via touchscreen with a custom environment known as the Bussey-Saksida touchscreen chamber. Cambridge Enterprise, the technology transfer office of the University of Cambridge, supported commercialization of the Bussey-Saksida chamber, culminating in a license to Campden Instruments. Any financial compensation received from commercialization of the technology is fully invested in further touchscreen development and/or maintenance. All other authors declare no competing interests.
ISSN:2692-8205
DOI:10.1101/2025.05.27.656174